APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sexual Dysfunction Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sexual Dysfunction Drugs Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchSexual Dysfunction Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Sexual Dysfunction Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sexual Dysfunction Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sexual Dysfunction Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sexual Dysfunction Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sexual Dysfunction Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sexual Dysfunction Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sexual Dysfunction Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sexual Dysfunction Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sexual Dysfunction Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sexual Dysfunction Drugs include Takeda, Teva Pharmaceutical Industries, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer, AbbVie and Vietstar Biomedical Research, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sexual Dysfunction Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sexual Dysfunction Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Sexual Dysfunction Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sexual Dysfunction Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sexual Dysfunction Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sexual Dysfunction Drugs sales, projected growth trends, production technology, application and end-user industry.

Sexual Dysfunction Drugs Segment by Company

Takeda

Teva Pharmaceutical Industries

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AbbVie

Vietstar Biomedical Research

S1 Biopharma

NexMed

Leadiant Biosciences

Ivix LLX

Emotional Brain

Apricus Biosciences

Sexual Dysfunction Drugs Segment by Type

Hormonal Therapy

Transurethral Therapy

Oral Therapy

Intracavernosal Therapy

Sexual Dysfunction Drugs Segment by Application

Male

Female

Sexual Dysfunction Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sexual Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sexual Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sexual Dysfunction Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sexual Dysfunction Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexual Dysfunction Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sexual Dysfunction Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hormonal Therapy Major Manufacturers Table 3. Transurethral Therapy Major Manufacturers Table 4. Oral Therapy Major Manufacturers Table 5. Intracavernosal Therapy Major Manufacturers Table 6. Global Sexual Dysfunction Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Male Major Manufacturers Table 8. Female Major Manufacturers Table 9. Sexual Dysfunction Drugs Industry Trends Table 10. Sexual Dysfunction Drugs Industry Drivers Table 11. Sexual Dysfunction Drugs Industry Opportunities and Challenges Table 12. Sexual Dysfunction Drugs Industry Restraints Table 13. Global Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Sexual Dysfunction Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Sexual Dysfunction Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Sexual Dysfunction Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Sexual Dysfunction Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Sexual Dysfunction Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Sexual Dysfunction Drugs Sales Market Share by Region (2021-2026) Table 22. Global Sexual Dysfunction Drugs Sales Market Share by Region (2027-2032) Table 23. Global Sexual Dysfunction Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Sexual Dysfunction Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Sexual Dysfunction Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Sexual Dysfunction Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Sexual Dysfunction Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Sexual Dysfunction Drugs Manufacturers, Product Type & Application Table 31. Global Sexual Dysfunction Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Sexual Dysfunction Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Sexual Dysfunction Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Sexual Dysfunction Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2026) Table 43. Global Sexual Dysfunction Drugs Sales Market Share by Type (2027-2032) Table 44. Global Sexual Dysfunction Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Sexual Dysfunction Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Sexual Dysfunction Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Sexual Dysfunction Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2026) Table 55. Global Sexual Dysfunction Drugs Sales Market Share by Application (2027-2032) Table 56. Global Sexual Dysfunction Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sexual Dysfunction Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Takeda Sexual Dysfunction Drugs Product Portfolio Table 62. Takeda Recent Development Table 63. Teva Pharmaceutical Industries Company Information Table 64. Teva Pharmaceutical Industries Business Overview Table 65. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio Table 67. Teva Pharmaceutical Industries Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck Sexual Dysfunction Drugs Product Portfolio Table 72. Merck Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eli Lilly Sexual Dysfunction Drugs Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Sexual Dysfunction Drugs Product Portfolio Table 82. Pfizer Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bayer Sexual Dysfunction Drugs Product Portfolio Table 92. Bayer Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AbbVie Sexual Dysfunction Drugs Product Portfolio Table 97. AbbVie Recent Development Table 98. Vietstar Biomedical Research Company Information Table 99. Vietstar Biomedical Research Business Overview Table 100. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio Table 102. Vietstar Biomedical Research Recent Development Table 103. S1 Biopharma Company Information Table 104. S1 Biopharma Business Overview Table 105. S1 Biopharma Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. S1 Biopharma Sexual Dysfunction Drugs Product Portfolio Table 107. S1 Biopharma Recent Development Table 108. NexMed Company Information Table 109. NexMed Business Overview Table 110. NexMed Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. NexMed Sexual Dysfunction Drugs Product Portfolio Table 112. NexMed Recent Development Table 113. Leadiant Biosciences Company Information Table 114. Leadiant Biosciences Business Overview Table 115. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio Table 117. Leadiant Biosciences Recent Development Table 118. Ivix LLX Company Information Table 119. Ivix LLX Business Overview Table 120. Ivix LLX Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Ivix LLX Sexual Dysfunction Drugs Product Portfolio Table 122. Ivix LLX Recent Development Table 123. Emotional Brain Company Information Table 124. Emotional Brain Business Overview Table 125. Emotional Brain Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Emotional Brain Sexual Dysfunction Drugs Product Portfolio Table 127. Emotional Brain Recent Development Table 128. Apricus Biosciences Company Information Table 129. Apricus Biosciences Business Overview Table 130. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio Table 132. Apricus Biosciences Recent Development Table 133. North America Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 136. North America Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 137. North America Sexual Dysfunction Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 138. North America Sexual Dysfunction Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 139. North America Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 142. North America Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 143. North America Sexual Dysfunction Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 144. North America Sexual Dysfunction Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 145. North America Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Sexual Dysfunction Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. North America Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 150. North America Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 151. North America Sexual Dysfunction Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 152. North America Sexual Dysfunction Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 153. United States Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 154. Canada Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 155. Europe Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 158. Europe Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 159. Europe Sexual Dysfunction Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 160. Europe Sexual Dysfunction Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 161. Europe Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 164. Europe Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 165. Europe Sexual Dysfunction Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 166. Europe Sexual Dysfunction Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Europe Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Sexual Dysfunction Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 171. Europe Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 172. Europe Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 173. Europe Sexual Dysfunction Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 174. Europe Sexual Dysfunction Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 175. Germany Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 176. France Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 177. U.K. Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 178. Italy Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 180. Nordic Countries Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 181. China Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 182. China Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 183. China Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 184. China Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 185. China Sexual Dysfunction Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 186. China Sexual Dysfunction Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 187. China Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 188. China Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 189. China Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 190. China Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 191. China Sexual Dysfunction Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 192. China Sexual Dysfunction Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Asia Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 196. Asia Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 197. Asia Sexual Dysfunction Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 198. Asia Sexual Dysfunction Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 199. Asia Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 202. Asia Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 203. Asia Sexual Dysfunction Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 204. Asia Sexual Dysfunction Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 205. Asia Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia Sexual Dysfunction Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. Asia Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 210. Asia Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 211. Asia Sexual Dysfunction Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 212. Asia Sexual Dysfunction Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Japan Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 214. South Korea Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 215. India Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 216. Australia Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 217. China Taiwan Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 219. SAMEA Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 222. SAMEA Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 223. SAMEA Sexual Dysfunction Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 224. SAMEA Sexual Dysfunction Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 225. SAMEA Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 228. SAMEA Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 229. SAMEA Sexual Dysfunction Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 230. SAMEA Sexual Dysfunction Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 231. SAMEA Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA Sexual Dysfunction Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 235. SAMEA Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 236. SAMEA Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 237. SAMEA Sexual Dysfunction Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 238. SAMEA Sexual Dysfunction Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 239. Brazil Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 240. Argentina Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 241. Chile Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 242. Colombia Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 243. Peru Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 245. Israel Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 246. UAE Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 247. Turkey Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 248. Iran Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 249. Egypt Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. Sexual Dysfunction Drugs Distributors List Table 253. Sexual Dysfunction Drugs Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Sexual Dysfunction Drugs Image Figure 2. Global Sexual Dysfunction Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sexual Dysfunction Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hormonal Therapy Image Figure 5. Transurethral Therapy Image Figure 6. Oral Therapy Image Figure 7. Intracavernosal Therapy Image Figure 8. Global Sexual Dysfunction Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Sexual Dysfunction Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Male Image Figure 11. Female Image Figure 12. Global Sexual Dysfunction Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Sexual Dysfunction Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Sexual Dysfunction Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Sexual Dysfunction Drugs Sales (2021-2032) & (K Units) Figure 18. Global Sexual Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Sexual Dysfunction Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Sexual Dysfunction Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Sexual Dysfunction Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Sexual Dysfunction Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Sexual Dysfunction Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Sexual Dysfunction Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Sexual Dysfunction Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Sexual Dysfunction Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Sexual Dysfunction Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Sexual Dysfunction Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Sexual Dysfunction Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Sexual Dysfunction Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Sexual Dysfunction Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Sexual Dysfunction Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Sexual Dysfunction Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Sexual Dysfunction Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Sexual Dysfunction Drugs Revenue Share by Type (2021-2032) Figure 41. North America Sexual Dysfunction Drugs Sales Share by Type (2021-2032) Figure 42. North America Sexual Dysfunction Drugs Revenue Share by Application (2021-2032) Figure 43. North America Sexual Dysfunction Drugs Sales Share by Application (2021-2032) Figure 44. North America Sexual Dysfunction Drugs Revenue Share by Country (2021-2032) Figure 45. North America Sexual Dysfunction Drugs Sales Share by Country (2021-2032) Figure 46. Europe Sexual Dysfunction Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Sexual Dysfunction Drugs Sales Share by Type (2021-2032) Figure 48. Europe Sexual Dysfunction Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Sexual Dysfunction Drugs Sales Share by Application (2021-2032) Figure 50. Europe Sexual Dysfunction Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Sexual Dysfunction Drugs Sales Share by Country (2021-2032) Figure 52. China Sexual Dysfunction Drugs Revenue Share by Type (2021-2032) Figure 53. China Sexual Dysfunction Drugs Sales Share by Type (2021-2032) Figure 54. China Sexual Dysfunction Drugs Revenue Share by Application (2021-2032) Figure 55. China Sexual Dysfunction Drugs Sales Share by Application (2021-2032) Figure 56. Asia Sexual Dysfunction Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Sexual Dysfunction Drugs Sales Share by Type (2021-2032) Figure 58. Asia Sexual Dysfunction Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Sexual Dysfunction Drugs Sales Share by Application (2021-2032) Figure 60. Asia Sexual Dysfunction Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Sexual Dysfunction Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Sexual Dysfunction Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Sexual Dysfunction Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Sexual Dysfunction Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Sexual Dysfunction Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Sexual Dysfunction Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Sexual Dysfunction Drugs Sales Share by Country (2021-2032) Figure 68. Sexual Dysfunction Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Sexual Dysfunction Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hormonal Therapy
  • Transurethral Therapy
  • Oral Therapy
  • Intracavernosal Therapy
Applications
  • Male
  • Female
Companies covered
  • Takeda
  • Teva Pharmaceutical Industries
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Vietstar Biomedical Research
  • S1 Biopharma
  • NexMed
  • Leadiant Biosciences
  • Ivix LLX
  • Emotional Brain
  • Apricus Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sexual Dysfunction Drugs Market by Type
  3. 1.2.1 Global Sexual Dysfunction Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hormonal Therapy
  5. 1.2.3 Transurethral Therapy
  6. 1.2.4 Oral Therapy
  7. 1.2.5 Intracavernosal Therapy
  8. 1.3 Sexual Dysfunction Drugs Market by Application
  9. 1.3.1 Global Sexual Dysfunction Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Male
  11. 1.3.3 Female
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Sexual Dysfunction Drugs Market Dynamics
  1. 2.1 Sexual Dysfunction Drugs Industry Trends
  2. 2.2 Sexual Dysfunction Drugs Industry Drivers
  3. 2.3 Sexual Dysfunction Drugs Industry Opportunities and Challenges
  4. 2.4 Sexual Dysfunction Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sexual Dysfunction Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sexual Dysfunction Drugs Revenue by Region
  3. 3.2.1 Global Sexual Dysfunction Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sexual Dysfunction Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Sexual Dysfunction Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Sexual Dysfunction Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sexual Dysfunction Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sexual Dysfunction Drugs Sales by Region
  9. 3.4.1 Global Sexual Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sexual Dysfunction Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Sexual Dysfunction Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Sexual Dysfunction Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers
  2. 4.1.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sexual Dysfunction Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sexual Dysfunction Drugs Sales by Manufacturers
  6. 4.2.1 Global Sexual Dysfunction Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sexual Dysfunction Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sexual Dysfunction Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sexual Dysfunction Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sexual Dysfunction Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sexual Dysfunction Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Sexual Dysfunction Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sexual Dysfunction Drugs Market CR5 and HHI
  16. 4.8.2 2025 Sexual Dysfunction Drugs Tier 1, Tier 2, and Tier 3
5 Sexual Dysfunction Drugs Market by Type
  1. 5.1 Global Sexual Dysfunction Drugs Revenue by Type
  2. 5.1.1 Global Sexual Dysfunction Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sexual Dysfunction Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sexual Dysfunction Drugs Sales by Type
  6. 5.2.1 Global Sexual Dysfunction Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sexual Dysfunction Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sexual Dysfunction Drugs Price by Type
6 Sexual Dysfunction Drugs Market by Application
  1. 6.1 Global Sexual Dysfunction Drugs Revenue by Application
  2. 6.1.1 Global Sexual Dysfunction Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sexual Dysfunction Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sexual Dysfunction Drugs Sales by Application
  6. 6.2.1 Global Sexual Dysfunction Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sexual Dysfunction Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sexual Dysfunction Drugs Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Sexual Dysfunction Drugs Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva Pharmaceutical Industries
  8. 7.2.1 Teva Pharmaceutical Industries Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Sexual Dysfunction Drugs Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Eli Lilly
  20. 7.4.1 Eli Lilly Company Information
  21. 7.4.2 Eli Lilly Business Overview
  22. 7.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly Sexual Dysfunction Drugs Product Portfolio
  24. 7.4.5 Eli Lilly Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Sexual Dysfunction Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Bayer
  38. 7.7.1 Bayer Company Information
  39. 7.7.2 Bayer Business Overview
  40. 7.7.3 Bayer Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bayer Sexual Dysfunction Drugs Product Portfolio
  42. 7.7.5 Bayer Recent Developments
  43. 7.8 AbbVie
  44. 7.8.1 AbbVie Company Information
  45. 7.8.2 AbbVie Business Overview
  46. 7.8.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AbbVie Sexual Dysfunction Drugs Product Portfolio
  48. 7.8.5 AbbVie Recent Developments
  49. 7.9 Vietstar Biomedical Research
  50. 7.9.1 Vietstar Biomedical Research Company Information
  51. 7.9.2 Vietstar Biomedical Research Business Overview
  52. 7.9.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio
  54. 7.9.5 Vietstar Biomedical Research Recent Developments
  55. 7.10 S1 Biopharma
  56. 7.10.1 S1 Biopharma Company Information
  57. 7.10.2 S1 Biopharma Business Overview
  58. 7.10.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 S1 Biopharma Sexual Dysfunction Drugs Product Portfolio
  60. 7.10.5 S1 Biopharma Recent Developments
  61. 7.11 NexMed
  62. 7.11.1 NexMed Company Information
  63. 7.11.2 NexMed Business Overview
  64. 7.11.3 NexMed Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 NexMed Sexual Dysfunction Drugs Product Portfolio
  66. 7.11.5 NexMed Recent Developments
  67. 7.12 Leadiant Biosciences
  68. 7.12.1 Leadiant Biosciences Company Information
  69. 7.12.2 Leadiant Biosciences Business Overview
  70. 7.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio
  72. 7.12.5 Leadiant Biosciences Recent Developments
  73. 7.13 Ivix LLX
  74. 7.13.1 Ivix LLX Company Information
  75. 7.13.2 Ivix LLX Business Overview
  76. 7.13.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ivix LLX Sexual Dysfunction Drugs Product Portfolio
  78. 7.13.5 Ivix LLX Recent Developments
  79. 7.14 Emotional Brain
  80. 7.14.1 Emotional Brain Company Information
  81. 7.14.2 Emotional Brain Business Overview
  82. 7.14.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Emotional Brain Sexual Dysfunction Drugs Product Portfolio
  84. 7.14.5 Emotional Brain Recent Developments
  85. 7.15 Apricus Biosciences
  86. 7.15.1 Apricus Biosciences Company Information
  87. 7.15.2 Apricus Biosciences Business Overview
  88. 7.15.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio
  90. 7.15.5 Apricus Biosciences Recent Developments
8 North America
  1. 8.1 North America Sexual Dysfunction Drugs Market Size by Type
  2. 8.1.1 North America Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Sexual Dysfunction Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Sexual Dysfunction Drugs Price by Type (2021-2032)
  5. 8.2 North America Sexual Dysfunction Drugs Market Size by Application
  6. 8.2.1 North America Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Sexual Dysfunction Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Sexual Dysfunction Drugs Price by Application (2021-2032)
  9. 8.3 North America Sexual Dysfunction Drugs Market Size by Country
  10. 8.3.1 North America Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sexual Dysfunction Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Sexual Dysfunction Drugs Market Size by Type
  2. 9.1.1 Europe Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sexual Dysfunction Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Sexual Dysfunction Drugs Price by Type (2021-2032)
  5. 9.2 Europe Sexual Dysfunction Drugs Market Size by Application
  6. 9.2.1 Europe Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sexual Dysfunction Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Sexual Dysfunction Drugs Price by Application (2021-2032)
  9. 9.3 Europe Sexual Dysfunction Drugs Market Size by Country
  10. 9.3.1 Europe Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sexual Dysfunction Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Sexual Dysfunction Drugs Market Size by Type
  2. 10.1.1 China Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Sexual Dysfunction Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Sexual Dysfunction Drugs Price by Type (2021-2032)
  5. 10.2 China Sexual Dysfunction Drugs Market Size by Application
  6. 10.2.1 China Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Sexual Dysfunction Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Sexual Dysfunction Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sexual Dysfunction Drugs Market Size by Type
  2. 11.1.1 Asia Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sexual Dysfunction Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Sexual Dysfunction Drugs Price by Type (2021-2032)
  5. 11.2 Asia Sexual Dysfunction Drugs Market Size by Application
  6. 11.2.1 Asia Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sexual Dysfunction Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Sexual Dysfunction Drugs Price by Application (2021-2032)
  9. 11.3 Asia Sexual Dysfunction Drugs Market Size by Country
  10. 11.3.1 Asia Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sexual Dysfunction Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sexual Dysfunction Drugs Market Size by Type
  2. 12.1.1 SAMEA Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sexual Dysfunction Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sexual Dysfunction Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Sexual Dysfunction Drugs Market Size by Application
  6. 12.2.1 SAMEA Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sexual Dysfunction Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sexual Dysfunction Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Sexual Dysfunction Drugs Market Size by Country
  10. 12.3.1 SAMEA Sexual Dysfunction Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sexual Dysfunction Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sexual Dysfunction Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sexual Dysfunction Drugs Value Chain Analysis
  2. 13.1.1 Sexual Dysfunction Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sexual Dysfunction Drugs Production Mode & Process
  6. 13.2 Sexual Dysfunction Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sexual Dysfunction Drugs Distributors
  9. 13.2.3 Sexual Dysfunction Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst